Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection

ConclusionIn Chinese AML patients, the posaconazole 300-mg tablet provided PK data comparable with those of previous studies and was generally well tolerated and efficacious.Clinical Trial RegistrationClinicalTrials.gov, NCT02387983.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research